EMAGLARA Trademark

Trademark Overview

On Thursday, March 26, 2026, a trademark application was filed for EMAGLARA with the United States Patent and Trademark Office. The USPTO has given the EMAGLARA trademark a serial number of 99727474. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, May 18, 2026. This trademark is owned by Amgen Inc.. The EMAGLARA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke
emaglara

General Information

Serial Number99727474
Word MarkEMAGLARA
Filing DateThursday, March 26, 2026
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, May 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicespharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic, and dermatitis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders; pharmaceutical preparations for the treatment of obesity, diabetes, cardiovascular, central nervous system diseases and disorders, metabolic disorders, and stroke

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 26, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799
US

Trademark Events

Event DateEvent Description
Thursday, March 26, 2026NEW APPLICATION ENTERED
Thursday, March 26, 2026APPLICATION FILING RECEIPT MAILED
Thursday, March 26, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 14, 2026ASSIGNED TO EXAMINER
Monday, May 18, 2026NON-FINAL ACTION WRITTEN
Monday, May 18, 2026NON-FINAL ACTION E-MAILED
Monday, May 18, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

emaglara preparations pharmaceutical treatment disorders diseases system obesity breathing asthma other